July 2008 Oncology News International

Publication
Article

Cover Story

Dr. Larry Norton & the Case of the Recurring Mass

Novel Agents May Overcome Resistance to Trastuzumab

DEPARTMENTS

Focus on Breast Cancer

Lapatinib Plus Trastuzumab Extends Progression-Free Survival in Women With HER2-Positive Metastatic Breast Cancer

International News

Bevacizumab Improves PFS in Advanced Breast Cancer

Focus on Lung Cancer

RNA Analysis Can Predict Lung Cancer Among Smokers

Focus on Prostate Cancer

Custirsen, an Antisense Oligonucleotide, May Enhance Docetaxel Efficacy in Hormone-Refractory Prostate Cancer

Vantage Point: Impressive' Pain results; Tolerability Questioned

Focus on Colon Cancer

KRAS Status Predicts Benefit for Cetuximab in Met Colon Ca

Recent Videos
Experts from Vanderbilt University Medical Center discuss the use of intraoperative radiation therapy in a 64-year-old patient with pancreatic cancer.
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Although no responses were observed in 11 patients receiving abemaciclib monotherapy, combination therapies with abemaciclib may offer clinical benefit.
Stacey A. Cohen, MD, and Daniel H. Ahn, DO, presenting slides
Stacey A. Cohen, MD, and Daniel H. Ahn, DO, presenting slides
Findings show no difference in overall survival between various treatments for metastatic RCC previously managed with immunotherapy and TKIs.
Related Content